Literature DB >> 823032

Pharmacokinetics--uses and abuses.

P J Fell, M T Stevens.   

Abstract

It is apparent from studying recent articles on pharmacokinetics that a number of misunderstandings exist, both about the design of experiments and the analysis of results. The purpose of this paper is to outline many of the common pitfalls associated with the design of experiments and also the limitations upon the analysis of results. The paper describes mathematical, laboratory and clinical aspects which must be examined in designing a protocol for pharmacokinetic experiments. Simulated data is presented to demonstrate the dangers of using standard computer programs for parameter estimation. Even when convergence is obtained the answers may be dependent on the method employed. A mathematical model is of little use unless a reasonable amount of good, accurate data is obtained.

Mesh:

Substances:

Year:  1975        PMID: 823032     DOI: 10.1007/BF00567122

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  VARIATION IN RATE OF SALICYLATE ELIMINATION BY HUMANS.

Authors:  G LEVY; L E HOLLISTER
Journal:  Br Med J       Date:  1964-08-01

2.  Kinetics of drug absorption, distribution, metabolism, and excretion.

Authors:  E NELSON
Journal:  J Pharm Sci       Date:  1961-03       Impact factor: 3.534

3.  Investigation of the effect of data error in the analysis of biological tracer data.

Authors:  J Myhill
Journal:  Biophys J       Date:  2008-12-31       Impact factor: 4.033

Review 4.  Pharmacokinetics.

Authors:  J G Wagner
Journal:  Annu Rev Pharmacol       Date:  1968       Impact factor: 13.820

5.  Absorption of drugs from the rat lung.

Authors:  S J Enna; L S Schanker
Journal:  Am J Physiol       Date:  1972-11

6.  The fate of pancuronium bromide in man.

Authors:  S Agoston; G A Vermeer; U W Kertsten; D K Meijer
Journal:  Acta Anaesthesiol Scand       Date:  1973       Impact factor: 2.105

7.  The binding of antibiotics to serum proteins.

Authors:  G N Rolinson; R Sutherland
Journal:  Br J Pharmacol Chemother       Date:  1965-12

8.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

9.  Intertissue diffusion effect for inert fat-soluble gases.

Authors:  W Perl; H Rackow; E Salanitre; G L Wolf; R M Epstein
Journal:  J Appl Physiol       Date:  1965-07       Impact factor: 3.531

10.  Commentary. Drug distribution and pharmacologic effects.

Authors:  M Gibaldi; G Levy; H Weintraub
Journal:  Clin Pharmacol Ther       Date:  1971 Sep-Oct       Impact factor: 6.875

View more
  12 in total

Review 1.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

2.  [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors:  H Kurz
Journal:  Klin Wochenschr       Date:  1978-12-15

3.  Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

4.  Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.

Authors:  H J Rogers; R G Spector; P J Morrison; I D Bradbrook
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

5.  Variability in derived parameters of furosemide pharmacokinetics.

Authors:  P Chennavasin; R A Johnson; D C Brater
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

6.  Curve fitting and modeling in pharmacokinetics: a response.

Authors:  C M Metzler; G L Elfring
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

7.  Optimal sampling times for pharmacokinetic experiments.

Authors:  D Z D'Argenio
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

8.  Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.

Authors:  D J Sumner; A J Russell
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 9.  Bioavailability of drugs: the digoxin dilemma.

Authors:  D J Greenblatt; T W Smith; J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Clinical pharmacokinetics of pancuronium bromide.

Authors:  A A Somogyi; C A Shanks; E J Triggs
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.